National Healthcare Corp. is classed by the SEC under Services-Skilled Nursing Care Facilities (industry code 8051), based in Murfreesboro, TN. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $1.5 billion and a profit of $120 million (its filed statements).
Usage businessServices-Skilled Nursing Care FacilitiesMurfreesboro, TNfilings since 19979 of 9 filed
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8051, Services-Skilled Nursing Care Facilities); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 6.3 out of ten, 9 of 9 metrics filed: past 5.7 out of ten, present 5.9 out of ten, future 7.5 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 3.9 out of ten. 1 warning event since 2017; the latest 2025-04-08. 39th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 6.6 out of ten. +5.7% a year over 10 filed years; profitable in 10 of 10. 66th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 6.8 out of ten. Share count grew 0.4% a year. 35% of cash flow returned. Insiders: 23 sales, 1 purchases. 68th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 6.2 out of ten. ROE 11%: 11¢ of profit per shareholder dollar. Leverage 30%: owes 30¢ per asset dollar. 62nd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 4.9 out of ten. bottom 49% of 22 in its family; net margin 7.9%. 49th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 7.5 out of ten. top 25% of 19 in its family for leadership; chief executive since 2017. 75th percentile among 19 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 7.9 out of ten. top 21% of 22 in its family for room to expand. 79th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 7.3 out of ten. top 27% of 22 in its family for growth drivers. 73rd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 7.5 out of ten. top 25% of 22 in its family for expectations against reality. 75th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-26 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-06 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-11 for the period ended 2026-08-07 (on EDGAR). Newest filing: Form 4, 2026-09-23. Filings on record since 1997. Read from EDGAR 2026-10-12.
Who runs it
Flatt, Stephen Fowler (CEO); Adams, Robert G (CEO); Ussery, Robert Michael (President & COO); Kidd, Brian F (SVP, CFO); Dodson, Vicki L (Sr.VP Patient Srvcs); Mccreary, Josh A (Senior VP & General Counsel); Flatt, Ben Anderson Sr (Senior VP & CIO); Laroche, Richard F Jr (Secretary); Shelly, Timothy J. (Sr.VP Operations); Gifford, David R. (director); and 5 more. 15 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.